TherapeuticsMD reported $1.41M in Operating Expenses for its fiscal quarter ending in June of 2024.





Operating Expenses Change Date
AbbVie USD 10.27B 538M Mar/2026
Alterity Therapeutics Limited AUD 8.67M 893.38K Dec/2025
Cipla INR 62.31B 3.04B Jun/2026
Clal Biotechnology ILS 5.15M 9.47M Dec/2022
Compugen USD 11.19M 96K Mar/2026
CSL USD 5.7B 2.82B Dec/2025
Grifols EUR 1.99B 217.4M Dec/2025
Novo Nordisk DKK 6.5B 32.8B Jun/2025
Pfizer USD 90.1B 77.19B Mar/2026
TherapeuticsMD USD 1.41M 50K Jun/2024